Although flow cytometric analysis indicated that RMP overexpression reduced the apoptosis rate of HCC cells treated with both cisplatin and TRAIL, there was a difference in mechanism between the two treatments. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.